NCT07325136
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07325136
Title A Study to Assess the Safety and Tolerability of BMS-986525 Alone and in Combination With Nivolumab in Participants With Relapsed/Refractory Small Cell Lung Cancer
Recruitment Not yet recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Bristol-Myers Squibb
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | ROU | ITA | ESP

Facility Status City State Zip Country Details
Local Institution - 0011 Detroit Michigan 48201 United States Details
Local Institution - 0026 Buffalo New York 14263 United States Details
Local Institution - 0005 Durham North Carolina 27710 United States Details
Local Institution - 0004 Cleveland Ohio 44106-5066 United States Details
Local Institution - 0006 Nashville Tennessee 37203 United States Details
Local Institution - 0001 Rozzano Milano 20089 Italy Details
Local Institution - 0020 Hirakata Osaka 573-1191 Japan Details
Local Institution - 0018 Chuo-ku Tokyo 104-0045 Japan Details
Local Institution - 0023 Timișoara Timiș County 300239 Romania Details
Local Institution - 0003 Craiova 200347 Romania Details
Local Institution - 0009 Madrid 28041 Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field